Claire S Waddington

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. pmc Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
    Claire S Waddington
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LJ
    BMJ 340:c2649. 2010

Collaborators

Detail Information

Publications1

  1. pmc Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
    Claire S Waddington
    Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LJ
    BMJ 340:c2649. 2010
    ..To compare the safety, reactogenicity, and immunogenicity of an adjuvanted split virion H1N1 vaccine and a non-adjuvanted whole virion vaccine used in the pandemic immunisation programme in the United Kingdom...